E6 TCR - Gilead
Kite Pharma: Corporate Presentaion (Kite Pharma) - Aug 13, 2015 - Anticipated IND filing for solid tumors in H1 2016 
Anticipated IND Oncology
http://files.shareholder.com/downloads/AMDA-2V2XOY/558415488x0x845642/4CA3FAA0-AC2B-45FA-B1AA-1BDF705230D3/Kite_Corporate_Presentation_-_August_2015_-_FINAL.pdf
 
Aug 13, 2015
 
.
 
058fb864-4365-4309-907b-1f181a948acb.jpg